Day: September 19, 2022

DALLAS, Sept. 19, 2022 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company management will participate in an upcoming investor conference: Jefferies Cell and Genetic Medicine SummitCompany presentation and Q&A: Thursday, September 29, 2022 at 10:30 a.m. ET A live webcast, if recorded, of the presentation can be accessed under “News & Events” in the Investors section of the Company’s website at www.instilbio.com. The archived webcast will be available on the Company’s website shortly after the event. About Instil BioInstil Bio, Inc. (Nasdaq: TIL) is a clinical-stage biopharmaceutical company focused on developing tumor infiltrating...

Reiterates financial guidance for positive Adjusted EBITDA1 profitability in 2022 Completion of BC Hydro power upgrade Maintains strong premium market position of 8.6%2 market share nationallyVANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to provide a corporate and operational update for the period ending August 31, 2022. Corporate Update The Company is pleased to reiterate its financial guidance from August 15, 2022 with its current expectation to be operating cashflow positive and Adjusted EBITDA profitable in fiscal 2022. As previously reported, the Company achieved positive Adjusted EBITDA in the three months ended...

OP Financial GroupInside informationStock exchange release 19 September 2022 at 13.15 OP Financial Group raises its earnings outlook for 2022 In its half-year financial report published on 27 July 2022, OP Financial Group expected its earnings before tax for 2022 to be lower than in 2021. Earnings before tax for 2021 were EUR 1,127 million. Based on a new estimate, OP Financial Group’s earnings before tax for 2022 are expected to be at about the same level or higher than in 2021 due to an increase in market rates.  Earnings performance continues to be affected by major uncertainty. Rising inflation and the war in Ukraine, including the related sanctions and counter-sanctions, are expected to substantially weaken the predictability associated with the economy and profit performance. In addition, inflation developments may cause uncertainty...

Noerresundby, Denmark, 19 September 2022Announcement no. 16/2022 RTX upgrades its revenue and earnings expectations for the financial year 2021/22 due to a stronger delivery performance in Q4 of 2021/22 than previously expected. The expected revenue in 2021/22 is upgraded from previously above DKK 550 to 610 million to now around DKK 650 million. The increase in expected revenue reflects a delivery performance in Q4 stronger than previously expected. The stronger delivery performance is driven by the component scarcity in the electronics industry beginning to improve, by successful component redesigns and by the absence of other extraordinary supply challenges such as lockdowns affecting production, shipping and logistics etc. in Q4. A shortage of components is still seen, but the situation has improved towards the end of RTX’s financial...